BioCryst Pharmaceuticals ...

8.54
-0.07 (-0.81%)
At close: Mar 03, 2025, 3:59 PM
8.54
0.06%
After-hours: Mar 03, 2025, 04:00 PM EST

BioCryst Pharmaceuticals Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95 FY94
Cash & Equivalents 104.71M 110.64M 304.77M 504.39M 272.13M 114.17M 26.73M 50.28M 22.1M 28.9M 54.54M 21.16M 20.89M 16.44M 13.62M 41.12M 22.34M 31.16M 4.42M 29.16M 8.84M 11.94M 13.82M 18.87M 8.46M 8.6M 12.3M 3.8M 3.6M 6.1M 2.7M
Short-Term Investments 216.14M 278.34M 119.54M 3.21M 28.24M 22.05M 77.74M 64.11M 32.55M 22.66M 18.23M 16.89M 14.71M 25.27M 40.32M 27.84M 39.19M 19.54M 33.04M 21.1M 14.33M 8.09M 10.62M 13.12M 16.18M 14.5M n/a n/a n/a n/a n/a
Long-Term Investments 20.32M n/a 18.08M 6.83M n/a n/a 22.38M 41.3M 8.93M 47.68M 41.12M 2.58M 1.15M 15.38M 11.77M 24.67M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 28.34M 80K -33.5M 6.47M 3.8M 3.59M 978K 2.03M 4.01M 5.73M 6.21M 3.86M 13.73M 2.17M -822.41K 2.63M 4.79M 45.72M 19.38M 15.55M 5.53M 5.71M 11.71M 20.95M 40.95M 46.8M 4.7M 5.1M 7.9M n/a n/a
Receivables n/a 56.95M 50.6M 29.41M 8.65M 22.15M 4.29M 6.12M 8.77M 6.24M 9.49M 2.12M 4.56M 7.57M 30.23M 33.72M 11.98M 39.13M 4.56M 30M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory 8.09M 28.68M 27.53M 15.79M 7.04M 1.55M 1.65M -37.8M 500K 1.61M 683K -2.36M -431K 263K 898.08K 6.28M -13.49B -41.01B -8.33B -51.94B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 13.96M 21.35M 14.06M 13.33M 7.75M 5.97M 3.94M 4.88M 3.07M 4.38M 6.4M 1.95M 1.82M 3.3M 2.35M 2.05M 1.51M 1.88M 3.78M 839.66K 699.28K 675.91K 483K 416.56K 1.12M 1.5M 10.6M 15.9M 24.5M 5.6M 8.4M
Total Current Assets 421.97M 495.97M 516.5M 566.14M 323.8M 164.34M 114.35M 125.39M 66.99M 65.99M 89.34M 42.12M 41.98M 63.56M 97.69M 111.02M 75.02M 91.7M 45.79M 81.1M 23.87M 20.7M 24.93M 32.4M 25.76M 24.6M 22.9M 19.7M 28.1M 11.7M 11.1M
Property-Plant & Equipment 19.79M 20.91M 15.42M 8.71M 7.11M 7.35M 9.13M 9.55M 9.92M 5.15M 207K 306K 583K 1.1M 1.93M 3.87M 4.88M 5.29M 3.03M 2.41M 2.82M 3.51M 4.56M 5.4M 3.84M 1.8M 1.4M 1.6M 1.1M 1.4M 1.7M
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 290.69K 187.63K 248.59K 179K 97.52K 343.02K 280.99K 200K 100K 100K n/a n/a n/a
Total Long-Term Assets 68.45M 20.99M 33.5M 22.02M 10.91M 10.94M 32.49M 52.87M 22.86M 58.56M 47.53M 6.75M 15.46M 18.65M 12.88M 31.17M 9.67M 51.01M 22.7M 18.15M 8.6M 9.39M 16.37M 26.69M 45.07M 48.8M 6.2M 6.8M 9M 1.4M 1.7M
Total Assets 490.42M 516.96M 550M 588.15M 334.71M 175.28M 146.84M 178.26M 89.85M 124.56M 136.87M 48.87M 57.44M 82.21M 110.57M 142.19M 84.69M 142.72M 68.49M 99.25M 32.47M 30.1M 41.3M 59.1M 70.83M 73.4M 29.1M 26.5M 37.1M 13.1M 12.8M
Account Payables 11.64M 20.89M 14.36M 27.81M 18.71M 13.99M 7.77M 6.34M 4.27M 9.31M 2.85M 4.17M 3.97M 2.5M 8.2M 18.07M 5.27M 19.77M 5.89M 8.81M 1.97M 640.35K 256K 617.59K 804.1K 300K 200K 200K 600K 400K 300K
Deferred Revenue n/a n/a 1.22M 1.42M 150K 2.12M 221K 8.48M 2.02M 2.16M 7.09M 1.47M 1.39M 9.79M 2.5M 2.5M 2.57M 4.66M 2.7M 873.79K 300M 300M 300M 300M 2.81B n/a n/a n/a n/a n/a n/a
Short-Term Debt 2.77M 2.65M 2.37M 1.82M 31.18M 39.96M 33.75M 35.22M 28.24M 27.8M 30M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 9.79K n/a n/a 100K 200K 300K 300K
Other Current Liabilities 145.97M 126.45M 87.16M 70.05M 55.53M 36.2M 27.69M 24.65M 19.77M 22.88M 17.68M 9.61M 11.86M 14.02M 17.3M 16.69M 9.28M 3.69M 2.15M 1.69M 863.92K 707.65K 616K 1.37M -38.06M 1.4M 900K 600K 600K 400K 200K
Total Current Liabilities 160.38M 149.99M 105.51M 103.72M 105.65M 92.33M 69.48M 74.84M 54.36M 64.45M 57.69M 15.26M 17.22M 12.28M 27.82M 37.25M 17.11M 28.12M 10.73M 11.38M 2.83M 1.35M 872.58K 1.98M 4.12M 1.7M 1.1M 900K 1.4M 1.1M 800K
Long-Term Debt 20.1M 822.5M 739.08M 591.42M 248.32M 44.7M 28.07M 19.5M 25.48M 2.38M n/a 30M 30M 30M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 100K 300K 600K
Other Long-Term Liabilities 785.87M n/a n/a n/a n/a n/a 54K 155K 244K 329K n/a n/a 4.75M 4M n/a 230.15K 220K n/a n/a n/a 300K 301K 300K 300K 5.22M 300K 300K 300K 200K 400K 200K
Total Long-Term Liabilities 805.97M 822.5M 739.08M 591.42M 248.32M 44.7M 28.13M 19.66M 33.91M 12.38M 3.55M 34.74M 40.67M 67.4M 16.12M 18.67M 21.16M 49.69M 36.6M 29.43M 300K 301K 300K 300K 5.22M 300K 300K 300K 300K 700K 800K
Total Liabilities 966.35M 972.49M 844.6M 695.14M 353.98M 137.03M 97.61M 94.49M 88.27M 76.83M 61.24M 49.99M 57.89M 67.4M 43.94M 55.92M 38.27M 77.81M 47.33M 40.81M 3.13M 1.65M 1.17M 2.28M 9.35M 2M 1.4M 1.2M 1.7M 1.8M 1.6M
Total Debt 12.82M 848.71M 741.45M 593.24M 124.72M 84.65M 61.82M 54.72M 53.72M 32.38M 30M 30M 30M 30M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 9.79K n/a n/a 100K 300K 600K 900K
Common Stock 2.08M 2.06M 1.88M 1.84M 1.77M 1.54M 1.1M 984K 738K 734K 720K 591K 509K 457K 449.59K 439.07K 382.75K 379.67K 292.49K 288.13K 217.58K 179K 176.57K 176.07K 175.37K 200K n/a n/a n/a n/a n/a
Retained Earnings -1.77B -1.68B -1.45B -1.21B -1.02B -840.63M -731.97M -631.84M -566.06M -510.92M -467.9M -422.71M -392.6M -353.52M -295.45M -262.72M -249.27M -224.54M -195.48M -151.86M -125.76M -104.66M -91.96M -75.03M -70.05M -58.5M -53.2M -48.4M -37.8M -30.1M -21.5M
Comprehensive Income 921K 1.34M 26K 177K 3K 39K -297K -243K -12K -206K -130K 4K 27K 40K 105.71K -25.78K 103.51K 378.06K 32.46K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity -475.93M -455.53M -1.45B -1.21B -1.02B -840.63M -731.97M -631.84M -566.06M -510.92M -467.9M -422.71M -392.6M 14.81M 66.62M 86.27M 46.43M 64.91M 21.16M 58.44M 29.33M 28.45M 40.13M 56.81M 61.48M 71.4M 27.7M 25.3M 35.4M 11.3M 11.2M
Total Investments 236.46M 278.34M 137.62M 10.04M 28.24M 22.05M 100.11M 105.41M 41.47M 70.35M 59.35M 19.47M 15.86M 40.66M 52.09M 52.51M 39.19M 19.54M 33.04M 21.1M 14.33M 8.09M 10.62M 13.12M 16.18M 14.5M n/a n/a n/a n/a n/a